[CYCC] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
30-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -0.75%
YoY- 34.10%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,369 -2,354 -1,531 -2,071 -2,076 -2,455 -1,861 17.43%
Tax -301 -502 -182 -200 -219 -268 -306 -1.09%
NP -2,068 -1,852 -1,349 -1,871 -1,857 -2,187 -1,555 20.91%
Tax Rate - - - - - - - -
Total Cost 2,068 1,852 1,349 1,871 1,857 2,187 1,555 20.91%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS -3.45 -3.09 -2.25 -3.14 -3.78 -9.86 -7.28 -39.18%
EPS Diluted -3.45 -3.09 -2.25 -3.12 -3.78 -9.86 -7.28 -39.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.